PHE_Scientific_Development of an Ovine Polyclonal Immunoglobulin Therapy

A Contract Award Notice
by PUBLIC HEALTH ENGLAND

Source
Contracts Finder
Type
Contract (Products)
Duration
1 year
Value
£27K
Sector
INDUSTRIAL
Published
09 Feb 2021
Delivery
17 Apr 2020 to 16 Apr 2021
Deadline
16 Apr 2020 12:00

Concepts

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

This requirement was to develop a rapid and effective therapy against infection by developing an ovine immunoglobulin treatment against the spike protein of Covid 19.

Award Detail

1 Native Antigen (Oxford)
  • Value: £26,523

CPV Codes

  • 24956000 - Peptones and protein substances

Indicators

  • Contract is suitable for SMEs.

Other Information

PHE discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health within the scope of the Civil Contingencies Act 2004 (CCA 2004). This urgent requirement is in response to the COVID -19 outbreak for the research of therapeutic antibodies.

Reference

Domains